Losing weight can be challenging as the body tries to prevent permanent weight loss (1). Yet, obese and overweight people must shed excess body weight to prevent the health risks associated with their conditions. According to a recent clinical trial, a newly approved type 2 diabetes drug, tirzepatide, may be a game-changer for effective weight…
Have you created your resolutions for the new year? Did you maybe plan to lose some weight in 2022? By stepping up the amount of exercise? While that might seem like a great idea, a new study by the International Atomic Agency (IAEA) has found that increasing physical activity is not necessarily the most efficient…
There are millions of gut microbes that live within every human being, and they all have a role to play in our overall health and wellness. A recent study (1) showed that good gut bacteria could aid weight loss in individuals carrying excess weight and those who are statistically overweight (as denoted through a BMI…
Cardiovascular disease is a common, but preventable, chronic condition. The key to preventing this disease is to follow a healthy diet (). But with so many diets being discussed online, you’re not alone in wondering about the cardiovascular benefits of following a fad diet. In June 2020, research carried out by Dr. D’Souza in Georgia…
In the United States, more than 42% of adults are obese. Obesity is linked to health complications, including diabetes and liver disease (). Research into obesity has commonly focused on dieting or weight loss medications. But now scientists are investigating a fat-burning molecule, BAM15, which could aid weight loss. How to Lose Fat Losing weight…
Bariatric surgery is the most effective treatment for obesity. However, since obesity is a chronic disease, many patients experience weight gain following Roux-en-Y gastric bypass surgery. A study by Nawfal Istfan published in May 2020 investigated whether anti-obesity drugs could reduce the risk of such weight regain (). Reasons for Post-RYGB Weight Gain Post-operative weight…
Treating obesity in childhood and teen years has always presented significant challenges for health professionals as options are significantly more limited than for adults. Even obesity drugs are less widely available, and other interventions are generally considered inappropriate. So far, the FDA has only approved two drugs for weight loss in young adults and teens:…
Obesity is a widespread epidemic in the United States, affecting 42.4 percent of Americans in 2018 (). This condition is defined by an excess of body fat that causes a body mass index reading of 30 or higher. Without obesity treatment, the disease can lead to several other severe medical conditions, including diabetes, heart disease,…
The ongoing COVID-19 pandemic has pushed wellness to the front of people’s minds. However, amidst constant public health messaging that encourages frequent hand washing and strict physical distancing, we’ve also seen another important message emerge: mental health matters too. In this uncertain time, health experts are more focused than ever on promoting behaviors that keep…
After receiving FDA approval in 2012, Belviq and Belviq XR (lorcaserin) rose to fame as a sustainable, pharmaceutical option for overweight and obese individuals interested in weight loss. The prescription-only medication worked by increasing feelings of fullness to help patients eat less, but new research suggests that long-term use may have also increased cancer risk….